BIOMAT Database Logo BIOMAT Database Logo

Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists. 1990

A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Department of Medicinal Chemistry, Pfizer Central Research, Groton, Connecticut 06340.

UI MeSH Term Description Entries
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012702 Serotonin Antagonists Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. 5-HT Antagonist,5-HT Antagonists,5-Hydroxytryptamine Antagonist,5-Hydroxytryptamine Antagonists,Antiserotonergic Agent,Antiserotonergic Agents,Serotonin Antagonist,Serotonin Blockader,Serotonin Blockaders,Serotonin Receptor Antagonist,Serotonin Receptor Blocker,Antagonists, 5-HT,Antagonists, 5-Hydroxytryptamine,Antagonists, Serotonin,Serotonin Receptor Antagonists,Serotonin Receptor Blockers,5 HT Antagonist,5 HT Antagonists,5 Hydroxytryptamine Antagonist,5 Hydroxytryptamine Antagonists,Agent, Antiserotonergic,Agents, Antiserotonergic,Antagonist, 5-HT,Antagonist, 5-Hydroxytryptamine,Antagonist, Serotonin,Antagonist, Serotonin Receptor,Antagonists, 5 HT,Antagonists, 5 Hydroxytryptamine,Antagonists, Serotonin Receptor,Blockader, Serotonin,Blockaders, Serotonin,Blocker, Serotonin Receptor,Blockers, Serotonin Receptor,Receptor Antagonist, Serotonin,Receptor Antagonists, Serotonin,Receptor Blocker, Serotonin,Receptor Blockers, Serotonin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
July 2004, Journal of medicinal chemistry,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.
June 2010, Bioorganic & medicinal chemistry,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Ligand-based design, synthesis, and pharmacological evaluation of 3-Methoxyquinoxalin-2-carboxamides as structurally novel serotonin type-3 receptor antagonists.
September 2012, Archiv der Pharmazie,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.
December 2011, Journal of medicinal chemistry,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.
March 2010, Bioorganic & medicinal chemistry letters,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
"Selective" serotonin 5-HT2A receptor antagonists.
June 2022, Biochemical pharmacology,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.
February 2004, Bioorganic & medicinal chemistry,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
November 2005, Journal of molecular modeling,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
A series of structurally novel heterotricyclic alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor-selective antagonists.
July 2010, British journal of pharmacology,
A A Nagel, and T Rosen, and J Rizzi, and J Daffeh, and K Guarino, and J Nowakowski, and L A Vincent, and J Heym, and S McLean, and T Seeger
Benzothiazinones: a novel class of adenosine receptor antagonists structurally unrelated to xanthine and adenine derivatives.
April 2012, Journal of medicinal chemistry,
Copied contents to your clipboard!